$NRXS
Neuraxis, INC Stock $nrxs

$nrxs Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224044538 Filed on November 12, 2024

Income Statement

Concept	2024 Q3
Revenue	$666.6K
YoY Change	39.62%
Cost Of Revenue	$97.05K
YoY Change	44.23%
Gross Profit	$569.6K
YoY Change	38.86%
Gross Profit Margin	85.44%
Selling, General & Admin	$2.148M
YoY Change	-36.58%
% of Gross Profit	377.2%
Research & Development	$72.42K
YoY Change	61.12%
% of Gross Profit	12.72%
Depreciation & Amortization	$9.270K
YoY Change	21.83%
% of Gross Profit	1.63%
Operating Expenses	$2.221M
YoY Change	-35.3%
Operating Profit	-$1.651M
YoY Change	-45.36%
Interest Expense	$64.68K
YoY Change	-36.98%
% of Operating Profit
Other Income/Expense, Net	$293.8K
YoY Change	-115.61%
Pretax Income	-$1.755M
YoY Change	-64.18%
Income Tax
% Of Pretax Income
Net Earnings	-$1.755M
YoY Change	-64.21%
Net Earnings / Revenue	-263.3%
Basic Earnings Per Share	-$0.25
Diluted Earnings Per Share	-$0.25
COMMON SHARES
Basic Shares Outstanding	6.842M shares
Diluted Shares Outstanding	7.172M shares

Balance Sheet

Concept	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$260.9K
YoY Change	-65.67%
Cash & Equivalents	$260.9K
Short-Term Investments
Other Short-Term Assets	$295.9K
YoY Change	639.78%
Inventory	$22.46K
Prepaid Expenses
Receivables	$52.59K
Other Receivables	$0.00
Total Short-Term Assets	$631.8K
YoY Change	-34.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$94.21K
YoY Change	17.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$20.16K
YoY Change
Total Long-Term Assets	$511.4K
YoY Change	90.08%
TOTAL ASSETS
Total Short-Term Assets	$631.8K
Total Long-Term Assets	$511.4K
Total Assets	$1.143M
YoY Change	-7.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$962.1K
YoY Change	69.79%
Accrued Expenses	$1.170M
YoY Change	317.68%
Deferred Revenue
YoY Change
Short-Term Debt	$147.7K
YoY Change	-23.87%
Long-Term Debt Due	$147.7K
YoY Change	-22.27%
Total Short-Term Liabilities	$2.664M
YoY Change	18.0%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities	$273.1K
YoY Change	582.7%
Total Long-Term Liabilities	$273.1K
YoY Change	593.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.664M
Total Long-Term Liabilities	$273.1K
Total Liabilities	$2.937M
YoY Change	27.87%
SHAREHOLDERS EQUITY
Retained Earnings	-$55.35M
YoY Change	28.0%
Common Stock	$6.980K
YoY Change	35.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.794M
YoY Change
Total Liabilities & Shareholders Equity	$1.143M
YoY Change	-7.5%

Cashflow Statement

Concept	2024 Q3
OPERATING ACTIVITIES
Net Income	-$1.755M
YoY Change	-64.21%
Depreciation, Depletion And Amortization	$9.270K
YoY Change	21.83%
Cash From Operating Activities	-$1.393M
YoY Change	-50.43%
INVESTING ACTIVITIES
Capital Expenditures	$4.370K
YoY Change	-91.26%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$4.370K
YoY Change	-91.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-107.2K
YoY Change	-103.0%
NET CHANGE
Cash From Operating Activities	-1.393M
Cash From Investing Activities	-4.370K
Cash From Financing Activities	-107.2K
Net Change In Cash	-1.504M
YoY Change	-311.89%
FREE CASH FLOW
Cash From Operating Activities	-$1.393M
Capital Expenditures	$4.370K
Free Cash Flow	-$1.397M
YoY Change	-51.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	NRXS	Financing Charges FinancingCharges		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	67287	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	256949	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	569575	usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001933567
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41775
	dei	Entity Registrant Name EntityRegistrantName	NEURAXIS, INC.
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-5079684
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 330
	dei	Entity Address City Or Town EntityAddressCityOrTown	Carmel
	dei	Entity Address State Or Province EntityAddressStateOrProvince	IN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	46032
	dei	City Area Code CityAreaCode	(812)
	dei	Local Phone Number LocalPhoneNumber	689-0791
	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	260885	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78560	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	52594	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	73167	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	22458	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	21220	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	295905	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	631842	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	242610	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	464402	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	436626	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	370189	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	94213	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	297842	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	99209	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	108073	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit		usd
CY2023Q4	NRXS	Share Liabilities Current ShareLiabilitiesCurrent		usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	NRXS	Financing Charges FinancingCharges		usd
CY2024Q3	us-gaap	Interest And Other Income InterestAndOtherIncome		usd
	us-gaap	Interest And Other Income InterestAndOtherIncome		usd
CY2024Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
	us-gaap	Inventory Write Down InventoryWriteDown		usd
	us-gaap	Paid In Kind Interest PaidInKindInterest		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	NRXS	Issuance Of Warrants For Noncash Consideration IssuanceOfWarrantsForNoncashConsideration		usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	NRXS	Offering Costs In Advance Of Sale Of Common Stock OfferingCostsInAdvanceOfSaleOfCommonStock		usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	NRXS	Recognition Of Right Of Use Asset RecognitionOfRightOfUseAsset		usd
	NRXS	Conversion Of Convertible Promissory Notes To Series B Preferred Stock ConversionOfConvertiblePromissoryNotesToSeriesBPreferredStock		usd
	NRXS	Fair Value Of Warrant Liabilities Of Warrants From Convertible Notes FairValueOfWarrantLiabilitiesOfWarrantsFromConvertibleNotes		usd
	NRXS	Fair Value Of Derivative Liabilities Of Conversion Feature From Convertible Notes FairValueOfDerivativeLiabilitiesOfConversionFeatureFromConvertibleNotes		usd
	NRXS	Fair Value Of Warrants From Debt Discount In Convertible Notes Classified As Additional Paid In Capital FairValueOfWarrantsFromDebtDiscountInConvertibleNotesClassifiedAsAdditionalPaidInCapital		usd
	NRXS	Writeoff Of Debt Discount On Convertible Notes Classified As Additional Paid In Capital WriteoffOfDebtDiscountOnConvertibleNotesClassifiedAsAdditionalPaidInCapital		usd
	us-gaap	Notes Issued1 NotesIssued1		usd
CY2023Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Address Address Line1 EntityAddressAddressLine1	11611 N. Meridian Street
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	NRXS
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6980227	shares
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	69663	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	348074	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	88552	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	70263	usd
CY2024Q3	us-gaap	Security Deposit SecurityDeposit	20163	usd
CY2024Q3	us-gaap	Assets Assets	1143269	usd
CY2023Q4	us-gaap	Assets Assets	509498	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	962106	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1204219	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1169774	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	401088	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	56387	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	49127	usd
CY2024Q3	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	147688	usd
CY2023Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	148062	usd
CY2024Q3	us-gaap	Deposits Deposits	84512	usd
CY2023Q4	us-gaap	Deposits Deposits	74947	usd
CY2024Q3	NRXS	Share Liabilities Current ShareLiabilitiesCurrent	227000	usd
CY2024Q3	NRXS	Warrant Liabilities WarrantLiabilities	16659	usd
CY2023Q4	NRXS	Warrant Liabilities WarrantLiabilities	8225	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2664126	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1885668	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	273075	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27071	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	273075	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	27071	usd
CY2024Q3	us-gaap	Liabilities Liabilities	2937201	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1912739	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6980227	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6980227	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6508897	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6508897	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	6980	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	6509	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	53548720	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	47148361	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-55351706	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48558111	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-1793932	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1403241	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1143269	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	509498	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	666625	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	477460	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1924760	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1928590	usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	97050	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	231000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	410173	usd
	us-gaap	Gross Profit GrossProfit	1667811	usd
	us-gaap	Gross Profit GrossProfit	1697590	usd
CY2024Q3	us-gaap	Selling Expense SellingExpense	95430	usd
CY2023Q3	us-gaap	Selling Expense SellingExpense	64210	usd
	us-gaap	Selling Expense SellingExpense	226374	usd
	us-gaap	Selling Expense SellingExpense	250933	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	72422	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	44950	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	132304	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	171536	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2052996	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3323352	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6999358	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6316411	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1651273	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3022339	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5690225	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5041290	usd
	NRXS	Financing Charges FinancingCharges	230824	usd
	NRXS	Financing Charges FinancingCharges	2772	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	64676	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	102628	usd
	us-gaap	Interest Expense InterestExpense	171934	usd
	us-gaap	Interest Expense InterestExpense	453869	usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	2103	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	2103	usd
CY2024Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	6726	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-592853	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	8434	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-791610	usd
CY2023Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	6394	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	198551	usd
CY2024Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	40888	usd
CY2023Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1331030	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	126387	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4881622	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4779069	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3649571	usd
CY2024Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	17072	usd
CY2023Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	9931	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	20032	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	11483	usd
CY2024Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	8743	usd
CY2023Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1578	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	585824	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	9008	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-103961	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5603024	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1103371	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7993095	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1755234	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-8625363	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6793596	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13034385	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.38
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.38
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.11
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7172229	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7172229	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3625519	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3625519	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6800810	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6800810	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2552007	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2552007	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-5573613	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2173408	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-7747021	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2235614	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-9982635	usd
CY2023Q3	NRXS	Stock Issued During Period Value Common Stock Issued Upon Initial Public Offering StockIssuedDuringPeriodValueCommonStockIssuedUponInitialPublicOffering	4860721	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	-1076	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	8966259	usd
CY2023Q3	NRXS	Stock Issued During Period Value Change In Fair Value Of Warrant Liability Upon Initial Public Offering StockIssuedDuringPeriodValueChangeInFairValueOfWarrantLiabilityUponInitialPublicOffering	3721007	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-8625363	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-1061087	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1403241	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1403241	usd
CY2024Q1	NRXS	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	26180	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	15543	usd
CY2024Q1	NRXS	Additional Paid In Capital From Warrants Issued As Debt Discount AdditionalPaidInCapitalFromWarrantsIssuedAsDebtDiscount	97465	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	200250	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2120651	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-3184454	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	44853	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	798929	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2917710	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-5258382	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-5258382	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	65426	usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	384832	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	-165577	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	4935003	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1755234	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-1793932	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-1793932	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6793596	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13034385	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	126387	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4881622	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	30980	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	30290	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	23156	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6380	usd
	us-gaap	Inventory Write Down InventoryWriteDown	2030	usd
	NRXS	Noncash Lease Expense NoncashLeaseExpense	29098	usd
	NRXS	Noncash Lease Expense NoncashLeaseExpense	23339	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	260777	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	227000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3649571	usd
	NRXS	Issuance Of Common Stock For Noncash Consideration IssuanceOfCommonStockForNoncashConsideration	1103124	usd
	NRXS	Issuance Of Common Stock For Noncash Consideration IssuanceOfCommonStockForNoncashConsideration	2550000	usd
	NRXS	Issuance Of Warrants For Noncash Consideration IssuanceOfWarrantsForNoncashConsideration	125824	usd
	NRXS	Finance Charges FinanceCharges	230824	usd
	NRXS	Finance Charges FinanceCharges	2772	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	198551	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	8434	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-791610	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2583	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-35637	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3268	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-13603	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-19767	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	37967	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-242112	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1025467	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	768686	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-415181	usd
	NRXS	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	9565	usd
	NRXS	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	9798	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3413	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-25047	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4340097	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4064419	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27776	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14741	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	41000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27776	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-55741	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5464642	usd
	NRXS	Offering Costs In Advance Of Sale Of Common Stock OfferingCostsInAdvanceOfSaleOfCommonStock	2417185	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	26180	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	216482	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3487578	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	159831	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	4740500	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	4908000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4550198	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4627710	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	182325	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	507550	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	78560	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	253699	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	260885	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	761249	usd
	us-gaap	Interest Paid Net InterestPaidNet	30756	usd
	us-gaap	Interest Paid Net InterestPaidNet	192015	usd
	NRXS	Recognition Of Right Of Use Asset RecognitionOfRightOfUseAsset	284339	usd
	NRXS	Conversion Of Convertible Promissory Notes To Series B Preferred Stock ConversionOfConvertiblePromissoryNotesToSeriesBPreferredStock	4935000	usd
	NRXS	Fair Value Of Warrant Liabilities Of Warrants From Convertible Notes FairValueOfWarrantLiabilitiesOfWarrantsFromConvertibleNotes	2446502	usd
	NRXS	Fair Value Of Derivative Liabilities Of Conversion Feature From Convertible Notes FairValueOfDerivativeLiabilitiesOfConversionFeatureFromConvertibleNotes	2375378	usd
	NRXS	Fair Value Of Warrants From Debt Discount In Convertible Notes Classified As Additional Paid In Capital FairValueOfWarrantsFromDebtDiscountInConvertibleNotesClassifiedAsAdditionalPaidInCapital	97465	usd
	NRXS	Writeoff Of Debt Discount On Convertible Notes Classified As Additional Paid In Capital WriteoffOfDebtDiscountOnConvertibleNotesClassifiedAsAdditionalPaidInCapital	165777	usd
	us-gaap	Notes Issued1 NotesIssued1	216110	usd
CY2023Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-2 reverse stock split
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1120000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_z7yHMGRoXub4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zTW4lsGOM9J4">Use of Estimates and Critical Accounting Estimates and Assumptions</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience, and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. The Company uses estimates in accounting for, among other items, revenue recognition, allowance for credit losses, stock-based compensation, income tax provisions, excess and obsolete inventory reserve, and impairment of property and equipment, and intellectual property. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5295914	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3107406	shares
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1755234	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-8625363	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6793596	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13034385	usd
CY2024Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	44820	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	44820	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1800054	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8625363	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6838416	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13034385	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7172229	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7172229	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3625519	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3625519	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6800810	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6800810	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2552007	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2552007	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.38
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.38
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.11
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-1793932	usd
CY2024Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	147688	usd
CY2024Q3	us-gaap	Cash Cash	260885	usd
CY2024Q3	NRXS	Working Capital Deficit WorkingCapitalDeficit	2032284	usd
CY2024Q3	NRXS	Allowance For Interest Receivable Current AllowanceForInterestReceivableCurrent	1012800	usd
CY2023Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1260504	shares
CY2023Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.001
CY2023Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3000000	usd
CY2023Q4	us-gaap	Debt Instrument Periodic Payment Terms Balloon Payment To Be Paid DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid	200000	usd
CY2024Q1	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	3135000	usd
CY2024Q1	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	3135000	usd
CY2024Q1	us-gaap	Convertible Debt ConvertibleDebt	3000000	usd
CY2024Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0740	pure
CY2024Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	166149	usd
CY2024Q3	us-gaap	Notes Payable NotesPayable	147688	usd
CY2024Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	18461	usd
	us-gaap	Debt Instrument Description DebtInstrumentDescription	The Company’s private placement agent fees included (i) 10% of the Original 2024 Convertible Promissory Notes funded principal amount and (ii) warrants calculated as 6.0% of the funded principal amount divided by the $2.38 exercise price. The fair value of the warrants of $97,465 were deferred as a financing fee and classified as additional paid in capital.
CY2024Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	66648	usd
CY2023Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	66648	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	64676	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	102628	usd
	us-gaap	Interest Expense InterestExpense	171934	usd
	us-gaap	Interest Expense InterestExpense	453869	usd
	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	The lease in Versailles started January 1, 2022 and has a term of one year, with automatic one year renewal, unless 60 day notice of vacating is given, commencing on the execution hereof and continuing through December 31st of each year. The current monthly lease payment for this lease is $1,800 with a 4% per annum increase. The new lease in Carmel started January 1, 2024. The initial term is five years and five months. The monthly lease payment started at $6,721 with an annual increase of 2.5%. As long as the Company is not in default, it is only obligated to pay an amount equal to 50% of the monthly base rent for months 1-10.
	us-gaap	Operating Lease Expense OperatingLeaseExpense	74314	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	35678	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	297842	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	70263	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	56387	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	49127	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	273075	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27071	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	329462	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	76198	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y4M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.150	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.150	pure
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	22203	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	105130	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	108106	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	86856	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	89027	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	38025	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	449347	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	119885	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	329462	usd
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6980227	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6980227	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6508897	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6508897	shares
CY2023Q3	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1244228	shares
CY2023Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	506637	shares
CY2023Q1	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	2-for-1 reverse stock split
CY2019Q3	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	Since the fair value was greater than the warrant price of $0.01 per share the holder elected to receive the number of shares equal to 40,000 times the difference between the fair market value and the exercise price divided by the fair market value, resulting in 39,924.
CY2024Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1902996	shares
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1319394	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y8M8D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.94
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1319394	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y8M8D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.94
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1319394	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y11M8D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.94
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1319394	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P4Y11M8D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	6.94
	us-gaap	Share Based Compensation ShareBasedCompensation	227000	usd
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
CY2024Q3	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	100000	shares
CY2024Q3	NRXS	Common Stock Capital Unissued Value CommonStockCapitalUnissuedValue	227000	usd
CY2024Q3	us-gaap	Other Expenses OtherExpenses	293791	usd
	us-gaap	Other Expenses OtherExpenses	580249	usd
CY2019Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	5000000	usd
CY2022Q3	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	75000	usd
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001493152-24-044538-index-headers.html	Edgar Link	pending
0001493152-24-044538-index.html	Edgar Link	pending
0001493152-24-044538.txt	Edgar Link	pending
0001493152-24-044538-xbrl.zip	Edgar Link	pending
ex3-1.htm	Edgar Link	pending
ex3-2.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nrxs-20240930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
nrxs-20240930_cal.xml	Edgar Link	unprocessable
nrxs-20240930_def.xml	Edgar Link	unprocessable
nrxs-20240930_lab.xml	Edgar Link	unprocessable
nrxs-20240930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NRXS
Neuraxis, INC Stock $nrxs

2024 Q3 Form 10-Q Financial Statement

#000149315224044538 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NRXS Neuraxis, INC Stock $nrxs

2024 Q3 Form 10-Q Financial Statement

#000149315224044538 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NRXS
Neuraxis, INC Stock $nrxs